Coya Therapeutics, Inc. (COYA)
5.02
+0.12
(+2.45%)
USD |
NASDAQ |
Feb 25, 16:00
5.02
0.00 (0.00%)
After-Hours: 20:00
Coya Therapeutics Research and Development Expense (Quarterly) : 2.917M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Eli Lilly & Co. | 3.802B |
| AbbVie, Inc. | 2.579B |
| Atea Pharmaceuticals, Inc. | 38.35M |
| ACADIA Pharmaceuticals, Inc. | 87.83M |
| Agenus, Inc. | 23.60M |